Tuberculosis cutis orificialis
Tuberculosis Cutis Orificialis
| Tuberculosis cutis orificialis | |
|---|---|
| ICD-10 | |
| ICD-9 | |
| DiseasesDB | |
| MedlinePlus | |
| eMedicine | |
| MeSH ID | |
Tuberculosis cutis orificialis is a rare form of cutaneous tuberculosis that occurs when Mycobacterium tuberculosis infects the skin at the mucocutaneous junctions, such as the mouth, anus, or genitals. This condition is typically seen in individuals with advanced pulmonary tuberculosis and is considered a sign of disseminated disease.
Clinical Presentation[edit]
Patients with tuberculosis cutis orificialis present with ulcerative lesions at the mucocutaneous junctions. These lesions are often painful and may bleed. The condition is more common in adults and is associated with a high bacterial load in the body.
Pathophysiology[edit]
The disease occurs when Mycobacterium tuberculosis spreads from an internal focus, such as the lungs, to the skin. The bacteria reach the skin through the bloodstream or lymphatic system and establish infection at sites where the skin meets mucous membranes.
Diagnosis[edit]
Diagnosis of tuberculosis cutis orificialis involves a combination of clinical examination and laboratory tests. A biopsy of the lesion can reveal granulomatous inflammation, and culture or polymerase chain reaction (PCR) can confirm the presence of Mycobacterium tuberculosis.
Treatment[edit]
The primary treatment for tuberculosis cutis orificialis is antitubercular therapy, which includes a combination of antibiotics such as isoniazid, rifampicin, ethambutol, and pyrazinamide. Treatment duration is typically 6 to 12 months, depending on the severity and response to therapy.
Prognosis[edit]
The prognosis for tuberculosis cutis orificialis depends on the control of the underlying tuberculosis infection. With appropriate treatment, the skin lesions can heal, although scarring may occur. However, if the systemic disease is not controlled, the prognosis is poor.
See Also[edit]
References[edit]
External Links[edit]
- [World Health Organization - Tuberculosis](https://www.who.int/health-topics/tuberculosis)
- [Centers for Disease Control and Prevention - Tuberculosis](https://www.cdc.gov/tb/)
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian